NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ABK Biomedical

ABK Biomedical

Private
HalifaxHealthcare & Life Scienceshttps://abkbiomedical.com/

Last Round

Series D

Oct 14, 2025

Total Funding Raised

$105.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ABK Biomedical is a medical technology company that develops innovative microspheres to enhance the treatment of hypervascular tumors through improved targeting of tumor vascularity and tissue.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

radioembolizationyttrium-90Y-90embolic microspheresliver cancer therapyradiopharmaceuticalinterventional radiologytargeted radiationmedical device manufacturertransarterial radioembolizationTAREoncology deviceimage-guided therapycancer interventionradioactive isotopes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ABK Biomedical Comparables

Compare ABK Biomedical with similar companies based on industry and business-model similarity.

ABK Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

ABK Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DOct 14, 2025
Series CDec 6, 2022
Series BApr 8, 2019
GrantFeb 22, 2018
Series AAug 1, 2017
Seed
Oct 24, 2012

Key People

Founding team and executive leadership

Michael Mangano

President And CEO, Member Board Of Directors

Executive Team

Mike Tyson

CFO

Executive Team

ABK Biomedical Investors

Notable investors and investment history

ABK Biomedical investors
InvestorRounds
InnovacorpSeed, Series A
F-Prime CapitalSeries C, Series D, Series B
Eight Roads VenturesSeries C, Series D
InnovacorpSeed, Series A, VC Round
Santé VenturesSeries D, Series C
Atlantic Canada Opportunities AgencyGrant, Seed
F-Prime CapitalSeries C, Series D, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Building a plant in Missouri for Eye90 microsphere technology.

  • Apr 8, 2026

    Partnering with COR Development to build a GMP facility in Missouri.

ABK Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ABK Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ABK Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHalifax
Employee Range42
Year Founded2012
Last FundingOct 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.